VREOF News and Press, Vireo Health International Inc From 12/18/25

2025-12-18 20:40:00 ET Listen here or on the go via Apple Podcasts or Spotify Josh Rosen and Jerry Derevyanny discuss the current state of cannabis investing, focusing on federal regulations, investment strategies, and the challenges of valuation in the cannabis sect...

2025-12-17 01:58:33 ET Vireo Growth (VREO) has signed an agreement to acquire several retail locations and properties from PharmaCann Inc. in Colorado for $49 million in an all-stock deal. ... Read the full article on Seeking Alpha For further details see: Vire...

Acquired assets further optimize Vireo’s operating footprint in Colorado with addition of 17 dispensaries Transaction expands Vireo’s leadership position in the Colorado retail market with 41 total dispensaries Parties also enter into Management Services Agreement th...

2025-11-12 10:22:54 ET More on Vireo Growth Vireo Growth Inc. (VREOF) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vireo Growth Historical earnings data for Vireo Growth Financial information for Vireo Growth Read the full...

2025-11-12 10:21:34 ET Vireo Growth Inc. (VREOF) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants John Mazarakis - CEO & Co-Executive Chairman Tyson Macdonald - Chief Financial Officer ... Read the full article on Seeking Alpha ...

2025-11-12 08:25:18 ET More on Vireo Growth Seeking Alpha’s Quant Rating on Vireo Growth Historical earnings data for Vireo Growth Financial information for Vireo Growth Read the full article on Seeking Alpha For further details see: Vireo ...

Q3 GAAP revenue of $91.7 million increased 264% year-over-year, driven by recently closed M&A transactions and organic growth throughout the portfolio Completed refinancing of senior secured debt which is expected to decrease annualized interest expense by $10 million Closed Q...

RWE AG ADR (RWEOY) is expected to report $0.16 for Q3 2025 Hillenbrand Inc (HI) is expected to report $0.62 for Q4 2025 Ardent Health Inc. (ARDT) is expected to report $0.42 for Q3 2025 Quince Therapeutics Inc. (QNCX) is expected to report $-0.2 for Q3 2025 GlobalFoundries Inc. (G...

MINNEAPOLIS, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its third fiscal quarter ended September 30, 2025 on Wednesday, November 12, 2025, before the market opens. Vir...

CHICAGO and MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Verano Holdings Corp. (“Verano”, Vireo and Verano, each a “Company”) (Cboe CA: VRNO) (OTCQX: VRNOF) today announced that they have reached...